Form 4: Guardant Health Executive Darya Chudova Reports Stock Transactions

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On April 1, 2024, Darya Chudova, the Chief Technology Officer of Guardant Health, Inc., engaged in transactions involving the company's common stock.
• Chudova acquired 1,340 shares of common stock through the vesting of restricted stock units (RSUs).
• Simultaneously, 527 shares were withheld by the company to cover tax obligations related to the RSU vesting at a price of $20.25 per share.
• Following these transactions, Chudova directly owns 36,304 shares of Guardant Health, Inc.
• The restricted stock units were granted on November 7, 2022, and vest over a four-year period.

Sentiment

Score: 6

Explanation: The document reflects routine executive compensation activity. It is neutral in sentiment as it doesn't indicate any significant positive or negative developments for the company.

Positives

• The vesting of restricted stock units indicates a continued commitment to the company by a key executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices through stock-based awards.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects standard executive compensation practices.

Key Dates